Findings support a model in which progression-relevant breast tissue remodeling may begin at the DH stage and nominate cellular states and candidate biomarkers for prospective validation in breast cancer risk stratification among patients with DH.
Stromal cell composition has been proposed as a potential biomarker in ductal carcinoma in situ (DCIS) for assessing the risk of subsequent recurrence or progression to invasive breast cancer (IBC). However, the characteristics of the tumor microenvironment within DCIS associated with these outcomes remain poorly under...
Nicola Graham, A. Turnbull, C. Martínez-Pérez et al.· bioRxiv· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) exhibits extensive cellular and molecular heterogeneity. How unique malignant states interact with and organize local microenvironments to drive therapy resistance and progression remains poorly understood, limiting tumour profiling and patient stratification. Existing binary t...
Noor Shakfa, Ferris Nowlan, Sibyl Drissler et al.· Cancer Research· 0 citations
Results demonstrate that CIS exhibits significant intra-patient heterogeneity not captured by single-site profiling, and support multi-region sampling, which could help improve risk stratification, biomarker development, and prediction of response to intravesical therapies.
Tyler D. Myers, A. Salmasi, M. Meagher et al.· bioRxiv· 0 citations
Backgroud Breast cancer is a leading cause of cancer-related mortality, and HR+/HER2− is the predominant subtype. Molecular pathology, including PIK3CA and ESR1 mutation, informs prognosis and treatment selection. Circulating tumor DNA (ctDNA) offers a non-invasive approach for cancer monitoring, but its clinical utili...
Heng-Yi Xu, Peng-Ming Pu, Bin-Liang Liu et al.· bioRxiv· 0 citations
Metastatic breast cancer remains incurable, underscoring the need for novel therapeutic strategies. Epidemiological and preclinical evidence suggests statins suppress metastatic outgrowth, however the underlying mechanisms remain unclear. We employed high-resolution spatial transcriptomics (ST) to explore the cellular...
Neha Atale, Jie Chen, Brian R. Isett et al.· Neoplasia· 0 citations